MEDIFLOR
DEAD

Serial Number

76975941

Owner

MERCK KGAA

Attorney

Brooks R. Bruneau

Filing Date

Sep 10, 2001

Add to watchlist:

No watchlists yet
View on USPTO

MEDIFLOR Trademark

Serial Number: 76975941 • Registration: 2906109

MEDIFLOR is a trademark filed by MERCK KGAA on September 10, 2001. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

MERCK KGAA (1,594 trademarks)

DARMSTADT 64293 , DE

Entity Type: 31

Trademark Details

Filing Date

September 10, 2001

Registration Date

November 30, 2004

Published for Opposition

September 7, 2004

Cancellation Date

July 1, 2011

Goods & Services

Nutraceuticals and pharmaceuticals for the care, hygiene, protection and treatment of irritated, inflamed and squamous skins, and seborrheic dermatitis, sensitive, greasy or dry skins, acne prone skin, psoriasis and complications thereof; nutraceuticals and pharmaceuticals for the treatment of the hair and of the scalp, namely, medicated hair oil, hair remedies, hair preservation treatment, dandruff cream, hair gel, hair lotion, hair mousse, hair conditioner, hair tonic, hair moisturizer, hair cream and shampoos; pharmaceutical and nutraceutical preparations for reduction of pigmentary marks of the skin; Pharmaceutical and nutraceutical preparations for anti-skin aging; medicated creams, pharmaceutical, nutraceutical and medical preparations for slimming purposes; cosmetic wipes with medicated creams; Pharmaceutical and nutraceutical preparations for skin care; for epidermis disorders, for blood disorders, for respiratory organ disorders, namely, prevention and treatment of asthma, chronic obstructive pulmonary disease, bronchitis and other respiratory ailments, and for the relief of bronchospasms; antibiotics; pharmaceuticals to lower blood glucose levels and for prevention and treatment of diabetes and complications thereof; vitamin preparations; pharmaceutical agents for activating cellular functioning; anti-inflammatory pharmaceuticals agents; pharmaceutical agents for digestive organs; drugs for circulatory organs; cerebral and peripheral anti-ischemic drugs, pharmaceuticals for the prevention and treatment of hypertension, angina pectoris and acute myocardial infarction; drugs for allergies, drugs for central and peripheral nervous system disorders; analgesics, soporifics, tranquilizers; drugs for the prevention and treatment of anxiety disorders, of insomnia; tumor suppressing pharmaceutical agents; syrups for pharmaceutical purposes namely, prevention and treatment of asthma, chronic obstructive pulmonary disease, bronchitis and other respiratory ailments, for the relief of bronchospasms, for the treatment of hypertension, for the treatment of angina pectoris and acute myocardial infarction, for the prevention and treatment of osteoarthritis and rheumatoid arthritis, for the prevention and treatment of anxiety disorders, for the treatment of insomnia, to lower blood glucose levels and for the prevention and treatment of diabetes and the complications thereof, for the treatment of central and peripheral nervous system disorders, to be used as analgesics, soporifics, tranquilizers; digestives aids, drugs for the prevention and treatment of osteoarthritis and rheumatoid arthritis, disinfectants for hygiene purposes, medical bath preparations, namely bath salts; Medicated ointments, pomades and aromatic preparations, all namely for the prevention and treatment of asthma, chronic obstructive pulmonary disease, bronchitis and other respiratory ailments, for the relief of bronchospasms, for the treatment of hypertension, for the treatment of angina pectoris and acute myocardial infarction, for the prevention and treatment of osteoarthritis and rheumatoid arthritis, for the prevention and treatment of anxiety disorders, for the treatment of insomnia, to lower blood glucose levels and for the prevention and treatment of diabetes and the complications thereof, for the treatment of central and peripheral nervous system disorders, to be used as analgesics, soporifics, tranquilizers; Dietary substances adapted for medical use, namely, food and herbal supplements, diet pills, medicinal herbs, medicinal infusions comprised of medicinal herbs, sugar for medicical purposes, dietetic and low calorie and sugar freefoods for weight loss and medical purposes, food for babies; medical plasters; wound dressing; dental wax; all purpose disinfectants; preparations for destroying vermin; fungicides; herbicides; herbal teas for medicinal purposes; Herbs and plants for pharmaceutical purposes namely, the prevention and treatment of asthma, chronic obstructive pulmonary disease, bronchitis and other respiratory ailments, for the relief of bronchospasms, for the treatment of hypertension, for the treatment of angina pectoris and acute myocardial infarction, for the prevention and treatment of osteoarthritis and rheumatoid arthritis, for the prevention and treatment of anxiety disorders, for the treatment of insomnia, to lower blood glucose levels and for the prevention and treatment of diabetes and the complications thereof, for the treatment of central and peripheral nervous system disorders, to be used as analgesics, soporifics, tranquilizers; Plant based pharmaceutical preparations, namely, preparations for the prevention and treatment of asthma, chronic obstructive pulmonary disease, bronchitis and other respiratory ailments, for the relief of bronchospasms, for the treatment of hypertension, for the treatment of angina pectoris and acute myocardial infarction, for the prevention and treatment of osteoarthritis and rheumatoid arthritis, for the prevention and treatment of anxiety disorders, for the treatment of insomnia, to lower blood glucose levels and for the prevention and treatment of diabetes and the complications thereof for the treatment of central and peripheral nervous system disorders, to be used as analgesics, soporifics, tranquilizers

Essential oils for personal use

Filing History

CANCELLED SEC. 8 (6-YR)
Jul 1, 2011 C8..
REGISTERED-PRINCIPAL REGISTER
Nov 30, 2004 R.PR
PUBLISHED FOR OPPOSITION
Sep 7, 2004 PUBO
NOTICE OF PUBLICATION
Aug 18, 2004 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 16, 2004 CNSA
FAX RECEIVED
Oct 20, 2003 FAXX
FAX RECEIVED
Oct 14, 2003 FAXX
LETTER OF SUSPENSION MAILED
Oct 8, 2003 CNSL
DIVISIONAL PROCESSING COMPLETE
Sep 3, 2003 DPCC
CASE FILE IN TICRS
Aug 18, 2003 CFIT
DIVISIONAL REQUEST RECEIVED
Jul 21, 2003 DRRR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 21, 2003 CRFA
PAPER RECEIVED
Jul 21, 2003 MAIL
NON-FINAL ACTION MAILED
Mar 12, 2003 CNRT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 3, 2003 CRFA
PAPER RECEIVED
Feb 3, 2003 MAIL
NON-FINAL ACTION MAILED
Jul 29, 2002 CNRT
Sec. 1(B) CLAIM DELETED
Jun 17, 2002 1.BD
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 17, 2002 CRFA
NON-FINAL ACTION MAILED
Dec 12, 2001 CNRT
ASSIGNED TO EXAMINER
Nov 30, 2001 DOCK